Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IMAX - CA45245E1097 - Common Stock

34.15 USD
+0.29 (+0.86%)
Last: 1/9/2026, 8:04:00 PM
33.9223 USD
-0.23 (-0.67%)
After Hours: 1/9/2026, 8:04:00 PM
Fundamental Rating

5

Overall IMAX gets a fundamental rating of 5 out of 10. We evaluated IMAX against 80 industry peers in the Entertainment industry. Both the profitability and the financial health of IMAX get a neutral evaluation. Nothing too spectacular is happening here. IMAX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
In the past year IMAX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

IMAX has a Return On Assets of 4.45%. This is in the better half of the industry: IMAX outperforms 80.00% of its industry peers.
With a decent Return On Equity value of 11.31%, IMAX is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.73%, IMAX belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
IMAX had an Average Return On Invested Capital over the past 3 years of 4.23%. This is below the industry average of 8.70%.
The 3 year average ROIC (4.23%) for IMAX is below the current ROIC(7.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With an excellent Profit Margin value of 10.47%, IMAX belongs to the best of the industry, outperforming 83.75% of the companies in the same industry.
In the last couple of years the Profit Margin of IMAX has declined.
Looking at the Operating Margin, with a value of 19.91%, IMAX belongs to the top of the industry, outperforming 91.25% of the companies in the same industry.
IMAX's Operating Margin has declined in the last couple of years.
IMAX has a better Gross Margin (58.89%) than 66.25% of its industry peers.
In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMAX is destroying value.
Compared to 1 year ago, IMAX has less shares outstanding
The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
Compared to 1 year ago, IMAX has a worse debt to assets ratio.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 2.61. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of IMAX (2.61) is better than 70.00% of its industry peers.
The Debt to FCF ratio of IMAX is 2.85, which is a good value as it means it would take IMAX, 2.85 years of fcf income to pay off all of its debts.
IMAX has a better Debt to FCF ratio (2.85) than 80.00% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that IMAX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.74, IMAX is not doing good in the industry: 61.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.61
ROIC/WACC0.84
WACC9.16%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

IMAX has a Current Ratio of 2.47. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
IMAX's Current ratio of 2.47 is fine compared to the rest of the industry. IMAX outperforms 80.00% of its industry peers.
A Quick Ratio of 2.12 indicates that IMAX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.12, IMAX is doing good in the industry, outperforming 77.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

IMAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.94%, which is quite impressive.
The Earnings Per Share has been decreasing by -2.17% on average over the past years.
The Revenue has grown by 9.30% in the past year. This is quite good.
IMAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.30% yearly.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%

3.2 Future

IMAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.13% yearly.
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y44.58%
EPS Next 2Y33.1%
EPS Next 3Y24.06%
EPS Next 5Y20.13%
Revenue Next Year11.56%
Revenue Next 2Y10.23%
Revenue Next 3Y8.88%
Revenue Next 5Y6.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.22, which means the current valuation is very expensive for IMAX.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.19. IMAX is around the same levels.
Based on the Price/Forward Earnings ratio of 20.29, the valuation of IMAX can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 82.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, IMAX is valued at the same level.
Industry RankSector Rank
PE 30.22
Fwd PE 20.29
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

70.00% of the companies in the same industry are more expensive than IMAX, based on the Enterprise Value to EBITDA ratio.
83.75% of the companies in the same industry are more expensive than IMAX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.36
EV/EBITDA 14.38
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMAX may justify a higher PE ratio.
IMAX's earnings are expected to grow with 24.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y33.1%
EPS Next 3Y24.06%

0

5. Dividend

5.1 Amount

No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield 0%

IMAX CORP

NYSE:IMAX (1/9/2026, 8:04:00 PM)

After market: 33.9223 -0.23 (-0.67%)

34.15

+0.29 (+0.86%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)02-17 2026-02-17
Inst Owners93%
Inst Owner Change0%
Ins Owners19.21%
Ins Owner Change-0.66%
Market Cap1.84B
Revenue(TTM)377.68M
Net Income(TTM)39.55M
Analysts82.22
Price Target43.78 (28.2%)
Short Float %9.77%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)10.04%
PT rev (3m)23.91%
EPS NQ rev (1m)0.66%
EPS NQ rev (3m)-8.89%
EPS NY rev (1m)0.56%
EPS NY rev (3m)8.73%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-4.58%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 30.22
Fwd PE 20.29
P/S 4.86
P/FCF 20.36
P/OCF 16.83
P/B 5.26
P/tB 7.31
EV/EBITDA 14.38
EPS(TTM)1.13
EY3.31%
EPS(NY)1.68
Fwd EY4.93%
FCF(TTM)1.68
FCFY4.91%
OCF(TTM)2.03
OCFY5.94%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.68
PEG (5Y)N/A
Graham Number12.85
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.61
F-Score8
WACC9.16%
ROIC/WACC0.84
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
EPS Next Y44.58%
EPS Next 2Y33.1%
EPS Next 3Y24.06%
EPS Next 5Y20.13%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%
Revenue Next Year11.56%
Revenue Next 2Y10.23%
Revenue Next 3Y8.88%
Revenue Next 5Y6.43%
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year234.24%
EBIT Next 3Y63.05%
EBIT Next 5Y38.42%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

Can you provide the ChartMill fundamental rating for IMAX CORP?

ChartMill assigns a fundamental rating of 5 / 10 to IMAX.


Can you provide the valuation status for IMAX CORP?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for IMAX CORP?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 44.58% in the next year.